Free Trial
Notice: Trading of Grail halted at 09:41 AM EST due to "LULD pause".

Grail (GRAL) Competitors

Grail logo
$40.73 -7.03 (-14.72%)
Closing price 04:00 PM Eastern
Extended Trading
$39.89 -0.84 (-2.06%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GRAL vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, VCYT, LFST, PRVA, and CON

Should you be buying Grail stock or one of its competitors? The main competitors of Grail include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Veracyte (VCYT), LifeStance Health Group (LFST), Privia Health Group (PRVA), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.

Grail vs.

Guardant Health (NASDAQ:GH) and Grail (NASDAQ:GRAL) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk, community ranking and dividends.

Grail has a net margin of 0.00% compared to Guardant Health's net margin of -74.02%. Grail's return on equity of 0.00% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-74.02% -1,200.44% -29.88%
Grail N/A N/A N/A

In the previous week, Grail had 1 more articles in the media than Guardant Health. MarketBeat recorded 22 mentions for Grail and 21 mentions for Guardant Health. Grail's average media sentiment score of 1.08 beat Guardant Health's score of 0.54 indicating that Grail is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
6 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Positive
Grail
8 Very Positive mention(s)
6 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Guardant Health received 288 more outperform votes than Grail when rated by MarketBeat users. Likewise, 70.59% of users gave Guardant Health an outperform vote while only 0.00% of users gave Grail an outperform vote.

CompanyUnderperformOutperform
Guardant HealthOutperform Votes
288
70.59%
Underperform Votes
120
29.41%
GrailOutperform Votes
No Votes
Underperform Votes
3
100.00%

Grail has lower revenue, but higher earnings than Guardant Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$563.95M9.39-$479.45M-$4.24-10.11
Grail$117.67M11.63N/AN/AN/A

Guardant Health currently has a consensus target price of $44.78, indicating a potential upside of 4.45%. Grail has a consensus target price of $16.00, indicating a potential downside of 60.72%. Given Guardant Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Guardant Health is more favorable than Grail.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
0 Strong Buy rating(s)
3.00
Grail
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

92.6% of Guardant Health shares are held by institutional investors. 5.5% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Guardant Health beats Grail on 8 of the 14 factors compared between the two stocks.

Get Grail News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRAL vs. The Competition

MetricGrailMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$1.41B$3.10B$5.81B$9.02B
Dividend YieldN/A20.51%4.78%3.85%
P/E RatioN/A15.8626.2318.96
Price / SalesN/A177.11453.4377.29
Price / CashN/A387.2444.0437.47
Price / BookN/A4.857.664.69
Net IncomeN/A-$22.21M$3.18B$245.69M
7 Day Performance-24.02%-3.58%-1.36%-1.85%
1 Month Performance126.10%0.25%0.73%-1.54%
1 Year PerformanceN/A14.62%17.60%14.60%

Grail Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRAL
Grail
1.0351 of 5 stars
$40.73
-14.7%
$16.00
-60.7%
N/A$1.37B$117.67M0.001,360Earnings Report
News Coverage
Positive News
Gap Up
Trading Halted
GH
Guardant Health
4.2444 of 5 stars
$48.12
+2.4%
$42.63
-11.4%
+107.6%$5.95B$563.95M-11.351,779Earnings Report
Analyst Forecast
News Coverage
OPCH
Option Care Health
4.0267 of 5 stars
$31.46
-1.1%
$32.25
+2.5%
-3.2%$5.35B$4.30B26.447,802Positive News
RDNT
RadNet
3.9248 of 5 stars
$61.33
-1.9%
$75.50
+23.1%
+66.2%$4.54B$1.62B-876.0210,288
BTSG
BrightSpring Health Services
1.8058 of 5 stars
$22.05
-0.1%
$19.42
-11.9%
+95.6%$3.84B$10.59B-84.8135,000
SHC
Sotera Health
2.1614 of 5 stars
$13.48
+0.4%
$16.08
+19.3%
-16.8%$3.82B$1.05B53.923,000Analyst Forecast
Negative News
SGRY
Surgery Partners
3.081 of 5 stars
$25.87
+0.3%
$36.56
+41.3%
-23.9%$3.29B$2.74B-53.9013,500
VCYT
Veracyte
2.9112 of 5 stars
$41.11
+3.8%
$42.00
+2.2%
+64.0%$3.19B$361.05M-274.07790Analyst Downgrade
News Coverage
LFST
LifeStance Health Group
1.5336 of 5 stars
$7.97
-0.3%
$8.70
+9.2%
+18.5%$3.05B$1.21B-30.659,325Upcoming Earnings
News Coverage
PRVA
Privia Health Group
3.238 of 5 stars
$25.24
+1.5%
$24.94
-1.2%
+19.1%$3.03B$1.72B252.431,102News Coverage
CON
Concentra Group Holdings Parent
N/A$22.69
-0.6%
$28.63
+26.1%
N/A$2.89B$1.84B0.0011,000Positive News

Related Companies and Tools


This page (NASDAQ:GRAL) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners